Diligent Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Diligent Pharma?

Diligent Pharma has 3 investors including GenHenn Venture And PJC.

Q: When was the last funding round for Diligent Pharma?

Diligent Pharma closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Diligent Pharma raised to date?

Diligent Pharma has raised obfuscated.

Overview

Diligent Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Diligent Pharma

CB Rank

34318

Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers.

Founded

obfuscation

Private

Series A

Philadelphia, Pennsylvania, United States

11-50

www.diligentpharma.com/

Computer

Industrial Manufacturing

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Key People

Patricia Leuchten: Founder and Owner
Past Role: The Avoca Group, Founder and CEO
LeRoy Jones: President

Details

Legal Name

Diligent Pharma, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Patricia Leuchten

About the Company

Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers. It simplifies and accelerates the process for identification, selection, and qualification of clinical trial service providers.

Trial sponsors can access standardized Vendor Qualification Assessment (VQA) reports and Request for

Information (RFI) information from Diligent. As a result, they will require significantly less time and money to qualify a GCP vendor before beginning a clinical investigation.

Phone Number

6096102815

Contact Email

support@diligentpharma.zendesk.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Diligent Qualification Platform

A centralized platform for qualifying and managing clinical trial service providers to streamline vendor selection, qualification, and oversight.

Vendor Qualification Assessments (VQA) and Audit Reports

Independent audits and qualification assessments of clinical trial service providers to verify compliance and operational capabilities.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A
obfuscated obfuscation	Series A - Diligent Pharma	3	obfuscated obfuscation	FCA Venture Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
GenHenn Venture	—	Series A - Diligent Pharma	—
GenHenn Venture	—	Series A - Diligent Pharma	—
GenHenn Venture	—	Series A - Diligent Pharma	—
GenHenn Venture	—	Series A - Diligent Pharma	—
GenHenn Venture	—	Series A - Diligent Pharma	—